A Prospective Study of Lumbar Facet Arthroplasty in the Treatment of Degenerative Spondylolisthesis and Stenosis: Results from the Total Posterior Spine System (TOPS) IDE Study.


Journal

Clinical spine surgery
ISSN: 2380-0194
Titre abrégé: Clin Spine Surg
Pays: United States
ID NLM: 101675083

Informations de publication

Date de publication:
01 03 2023
Historique:
received: 14 12 2021
accepted: 18 05 2022
pubmed: 4 10 2022
medline: 3 3 2023
entrez: 3 10 2022
Statut: ppublish

Résumé

Prospective randomized Food and Drug Administration investigational device exemption clinical trial. The purpose of the present study is to report the 1-year clinical and radiographic outcomes and safety profile of patients who underwent lumbar facet arthroplasty through implantation of the Total Posterior Spine System (TOPS) device. Lumbar facet arthroplasty is one proposed method of dynamic stabilization to treat grade-1 spondylolisthesis with stenosis; however, there are currently no Food and Drug Administration-approved devices for facet arthroplasty. Standard demographic information was collected for each patient. Radiographic parameters and patient-reported outcome measures were assessed preoperatively and at regular postoperative intervals. Complication and reoperation data were also collected for each patient. At the time of this study, 153 patients had undergone implantation of the TOPS device. The mean surgical time was 187.8 minutes and the mean estimated blood loss was 205.7cc. The mean length of hospital stay was 3.0 days. Mean Oswestry Disability Index, Visual Analog Score leg and back, and Zurich Claudication Questionnaire scores improved significantly at all postoperative time points ( P >0.001). There were no clinically significant changes in radiographic parameters, and all operative segments remained mobile at 1-year follow-up. Postoperative complications occurred in 11 patients out of the 153 patients (7.2%) who underwent implantation of the TOPS device. Nine patients (5.9%) underwent a total of 13 reoperations, 1 (0.6%) of which was for device-related failure owing to bilateral L5 pedicle screw loosening. Lumbar facet arthroplasty with the TOPS device demonstrated a statistically significant improvement in all patient-reported outcome measures and the ability to maintain motion at the index level while limiting sagittal translation with a low complication rate.

Sections du résumé

STUDY DESIGN
Prospective randomized Food and Drug Administration investigational device exemption clinical trial.
OBJECTIVE
The purpose of the present study is to report the 1-year clinical and radiographic outcomes and safety profile of patients who underwent lumbar facet arthroplasty through implantation of the Total Posterior Spine System (TOPS) device.
SUMMARY OF BACKGROUND DATA
Lumbar facet arthroplasty is one proposed method of dynamic stabilization to treat grade-1 spondylolisthesis with stenosis; however, there are currently no Food and Drug Administration-approved devices for facet arthroplasty.
METHODS
Standard demographic information was collected for each patient. Radiographic parameters and patient-reported outcome measures were assessed preoperatively and at regular postoperative intervals. Complication and reoperation data were also collected for each patient.
RESULTS
At the time of this study, 153 patients had undergone implantation of the TOPS device. The mean surgical time was 187.8 minutes and the mean estimated blood loss was 205.7cc. The mean length of hospital stay was 3.0 days. Mean Oswestry Disability Index, Visual Analog Score leg and back, and Zurich Claudication Questionnaire scores improved significantly at all postoperative time points ( P >0.001). There were no clinically significant changes in radiographic parameters, and all operative segments remained mobile at 1-year follow-up. Postoperative complications occurred in 11 patients out of the 153 patients (7.2%) who underwent implantation of the TOPS device. Nine patients (5.9%) underwent a total of 13 reoperations, 1 (0.6%) of which was for device-related failure owing to bilateral L5 pedicle screw loosening.
CONCLUSIONS
Lumbar facet arthroplasty with the TOPS device demonstrated a statistically significant improvement in all patient-reported outcome measures and the ability to maintain motion at the index level while limiting sagittal translation with a low complication rate.

Identifiants

pubmed: 36191093
doi: 10.1097/BSD.0000000000001365
pii: 01933606-202303000-00007
pmc: PMC9949521
doi:

Substances chimiques

TOPS 3474-22-4

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

E59-E69

Informations de copyright

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Martin BI, Mirza SK, Spina N, et al. Trends in lumbar fusion procedure rates and associated hospital costs for degenerative spinal diseases in the United States, 2004 to 2015. Spine. 2019;44:369–376.
Cheh G, Bridwell KH, Lenke LG, et al. Adjacent segment disease followinglumbar/thoracolumbar fusion with pedicle screw instrumentation: a minimum 5-year follow-up. Spine. 2007;32:2253–2257.
Eck JC, Humphreys SC, Hodges SD. Adjacent-segment degeneration after lumbar fusion: a review of clinical, biomechanical, and radiologic studies. Am J Orthop. 1999;28:336–340.
Kim TH, Lee BH, Moon SH, et al. Comparison of adjacent segment degeneration after successful posterolateral fusion with unilateral or bilateral pedicle screw instrumentation: a minimum 10-year follow-up. Spine J. 2013;13:1208–1216.
Schlegel JD, Smith JA, Schleusener RL. Lumbar motion segment pathology adjacent to thoracolumbar, lumbar, and lumbosacral fusions. Spine. 1996;21:970–981.
Mulholland RC, Sengupta DK. Rationale, principles and experimental evaluation of the concept of soft stabilization. Eur Spine J. 2002;11:S198–S205.
Heuer F, Schmidt H, Käfer W, et al. Posterior motion preserving implants evaluated by means of intervertebral disc bulging and annular fiber strains. Clin Biomech. 2012;27:218–225.
Meyers K, Tauber M, Sudin Y, et al. Use of instrumented pedicle screws to evaluate load sharing in posterior dynamic stabilization systems. Spine J. 2008;8:926–932.
Wilke HJ, Schmidt H, Werner K, et al. Biomechanical evaluation of a new total posterior-element replacement system. Spine. 2006;31:2790–2796.
Stoll TM, Dubois G, Schwarzenbach O. The dynamic neutralization system for the spine: a multi-center study of a novel non-fusion system. Eur Spine J. 2002;11(Suppl 2):S170–S178.
Anekstein Y, Floman Y, Smorgick Y, et al. Seven years follow-up for total lumbar facet joint replacement (TOPS) in the management of lumbar spinal stenosis and degenerative spondylolisthesis. Eur Spine J. 2015;24:2306–2314.
McAfee P, Khoo LT, Pimenta L, et al. Treatment of lumbar spinal stenosis with a total posterior arthroplasty prosthesis: implant description, surgical technique, and a prospective report on 29 patients. Neurosurg Focus. 2007;22:E13.
Smorgick Y, Mirovsky Y, Floman Y, et al. Long-term results for total lumbar facet joint replacement in the management of lumbar degenerative spondylolisthesis. J Neurosurg Spine. 2019;32:1–6.
Meyerding HW. Spondyloptosis. Surg Gynecol Obstet. 1932;54:371–377.
Lurie JD, Tosteson AN, Tosteson TD, et al. Reliability of readings of magnetic resonance imaging features of lumbar spinal stenosis. Spine . 2008;33:1605–1610.
Fairbank JC, Couper J, Davies JB, et al. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980;66:271–273.
Stucki G, Daltroy L, Liang MH, et al. Measurement properties of a self-administered outcome measure in lumbar spinal stenosis. Spine. 1996;21:796–803.
Carragee EJ, Cheng I. Minimum acceptable outcomes after lumbar spinal fusion. Spine J. 2010;10:313–320.
Kovacs FM, Abraira V, Royuela A, et al. Minimal clinically important change for pain intensity and disability in patients with nonspecific low back pain. Spine. 2007;32:2915–2920.
Fukushima M, Oka H, Oshima Y, et al. Evaluation of the minimum clinically important differences of the zurich claudication questionnaire in patients with lumbar spinal stenosis. Clin Spine Surg. 2020;33:E499–E503.
de Kunder S, Rijkers K, Van Hemert W, et al. Transforaminal versus posterior lumbar interbody fusion as operative treatment of lumbar spondylolisthesis, a retrospective case series. Interdiscip Neurosurg. 2016;5:64–68.
Han S-Y, Xiao Q, Zhu G-T, et al. Comparison between transforaminal lumbar interbody fusion and posterior lumbar interbody fusion in treatment of lumbar spondylolisthesis. Int J Clin Exp Med. 2016;9:3932–3938.
Liu J, Deng H, Long X, et al. A comparative study of perioperative complications between transforaminal versus posterior lumbar interbody fusion in degenerative lumbar spondylolisthesis. Eur Spine J. 2016;25:1575–1580.
Park J-S, Kim Y-B, Hong H-J, et al. Comparison between posterior and transforaminal approaches for lumbar interbody fusion. J Korean Neurosurg Soc. 2005;37:340–344.
Sakeb N, Ahsan K. Comparison of the early results of transforaminal lumbar interbody fusion and posterior lumbar interbody fusion in symptomatic lumbar instability. Ind J Orthop. 2013;47:255–263.
Yang EZ, Xu JG, Liu XK, et al. An RCT study comparing the clinical and radiological outcomes with the use of PLIF or TLIF after instrumented reduction in adult isthmic spondylolisthesis. Eur Spine J. 2016;25:1587–1594.
de Kunder SL, van Kuijk SMJ, Rijkers K, et al. Transforaminal lumbar interbody fusion (TLIF) versus posterior lumbar interbody fusion (PLIF) in lumbar spondylolisthesis: a systematic review and meta-analysis. Spine J. 2017;17:1712–1721.
Kerolus MG, Yerneni K, Witiw CD, et al. Enhanced recovery after surgery pathway for single-level minimally invasive transforaminal lumbar interbody fusion decreases length of stay and opioid consumption. Neurosurgery. 2021;88:648–657.
Siemionow K, Pelton MA, Hoskins JA, et al. Predictive factors of hospital stay in patients undergoing minimally invasive transforaminal lumbar interbody fusion and instrumentation. Spine. 2012;37:2046–2054.
Asil K, Yaldiz C. Retrospective comparison of radiological and clinical outcomes of PLIF and TLIF techniques in patients who underwent lumbar spinal posterior stabilization. Medicine. 2016;95:e3235.
Fariborz S, Gharedaghi M, Khosravi AF, et al. Comparison of results of 4 methods of surgery in grade 1 lumbosacral spondylolisthesis. Neurosurg Quart. 2016;26:14–18.
Yan D-l, Pei F-x, Li J, et al. Comparative study of PILF and TLIF treatment in adult degenerative spondylolisthesis. Eur Spine J. 2008;17:1311–1316.
Cummins D, Hindoyan K, Wu H-H, et al. Reoperation and mortality rates following elective 1 to 2 level lumbar fusion: a large state database analysis. Glob Spine J. 2021;00:2192568220986148.
Huang YP, Du CF, Cheng CK, et al. Preserving posterior complex can prevent adjacent segment disease following posterior lumbar interbody fusion surgeries: a finite element analysis. PLoS ONE. 2016;11:e0166452.
Haleem S, Ahmed A, Ganesan S, et al. Mean 5-year follow-up results of a facet replacement device in the treatment of lumbar spinal stenosis and degenerative spondylolisthesis. World Neurosurg. 2021;152:e645–e651.

Auteurs

Zachariah W Pinter (ZW)

Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN.

Brett A Freedman (BA)

Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN.

Ahmad Nassr (A)

Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN.

Arjun S Sebastian (AS)

Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN.

Domagoj Coric (D)

Carolinas Neurosurgery & Spine Associates, Charlotte, NC.

William C Welch (WC)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

Michael P Steinmetz (MP)

Department of Neurological Surgery, Cleveland Clinic Foundation, Cleveland, OH.

Stephen E Robbins (SE)

Wisconsin Bone & Joint, Milwaukee, WI.

Jared Ament (J)

Sierra Neuroscience Institute, Glendale, CA.

Neel Anand (N)

Cedars-Sinai Medical Center, Los Angeles, CA.

Paul Arnold (P)

Carle Neuroscience Institute, Urbana, IL.

Eli Baron (E)

Cedars-Sinai Medical Center, Los Angeles, CA.

Jason Huang (J)

Baylor Scott & White, Temple, TX.

Robert Whitmore (R)

Lahey Clinic Medical Center, Burlington, MA.

Donald Whiting (D)

Allegheny General Hospital, Pittsburgh, Pennsylvania.

David Tahernia (D)

Desert Orthopedic Center, Rancho Mirage, CA.

Faheem Sandhu (F)

MedStar Georgetown University Hospital, District of Columbia, WA.

Ali Chahlavi (A)

Ascension St. Vincent's Southside, Jacksonville, FL.

Joseph Cheng (J)

University of Cincinnati, Cincinnati, OH.

John Chi (J)

Brigham and Women's Hospital, Boston, MA.

Stephen Pirris (S)

Ascension St. Vincent's Southside, Jacksonville, FL.

Michael Groff (M)

Brigham and Women's Hospital, Boston, MA.

Alain Fabi (A)

Bronson Methodist Hospital, Kalamazoo, MI.

Scott Meyer (S)

Altair Health, Morristown, NJ.

Vivek Kushwaha (V)

Orthopaedic Associates, Bellaire, TX.

Roland Kent (R)

Axis Spine Center, Post Falls, ID.

Steven DeLuca (S)

Orthopedic Institute of Pennsylvania, Harrisburg, PA.

Yossi Smorgick (Y)

Shamir Medical Center, Zerifin, Israel, affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv Israel.

Yoram Anekstein (Y)

Shamir Medical Center, Zerifin, Israel, affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH